Orser Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
2021
Q2
$220K Buy
2021
Q1
Sell
2020
Q4
$208K Buy
2018
Q3
Sell
2018
Q2
$1.1M Buy